| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |